|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/05 | (2006.01) |
| A61K 45/06 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 31/05 | (2013.01) | ||
| A61K 36/185 | (2006.01) | ||
| A61K 36/185 | (2013.01) | ||
| A61P 25/08 | (2006.01) | ||
| A61P 25/08 | (2018.01) | ||
| A61K 31/192 | (2006.01) | ||
| A61K 31/192 | (2013.01) |
| (11) | Number of the document | 3769755 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20182674.0 |
| Date of filing the European patent application | 2016-07-29 | |
| (97) | Date of publication of the European application | 2021-01-27 |
| (45) | Date of publication and mention of the grant of the patent | 2023-05-24 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201514079 | 2015-08-10 | GB |
| (72) |
STOTT, Colin , GB
JONES, Nicholas , GB
WILLIAMS, Robin , GB
WHALLEY, Benjamin , GB
|
| (73) |
GW Research Limited ,
Sovereign House, Vision Park
Histon, Cambridge, CB24 9BZ,
GB
|
| (54) | USE OF CANNABIDIOLIC ACID IN THE TREATMENT OF EPILEPSY |
| USE OF CANNABIDIOLIC ACID IN THE TREATMENT OF EPILEPSY |